Physician profile
Patrick H Dunn
NPI 1477580868
$311.56
in general payments reported to CMS, 2019-2025
14 companies · $99.26 in 2025
The $99.26 reported for 2025 was less than what a typical Surgical provider received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $57.81 · 2022: $12.53 · 2023: $13.32 · 2024: $129 · 2025: $99.26.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $241.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $241.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $45.90 | 2024-2025 | Orthovisc, Monovisc, Milagro |
| Djo, LLC | $35.23 | 2024 | Cmf |
| Baxter Healthcare | $28.59 | 2024 | Floseal |
| Vertex Pharmaceuticals Incorporated | $24.60 | 2025 | |
| Medtronic, INC. | $23.06 | 2021 | |
| Abbott Laboratories | $22.59 | 2025 | Eterna |
| Heron Therapeutics, INC. | $21.44 | 2025 | Zynrelef |
| Becton, Dickinson and Company | $20.41 | 2024 | Arista Ah Flexitip |
| Convatec INC. | $19.72 | 2024 | |
| Ferring Pharmaceuticals INC. | $17.73 | 2021 | |
| Mayne Pharma Commercial LLC | $17.02 | 2021 | |
| Bioventus LLC | $13.32 | 2023 | Exogen Ultrasound Bone Healing System |
| Zimvie INC. | $12.53 | 2022 | |
| Biocomposites INC | $9.42 | 2025 | Stimulan |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Dunn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.